Orion Capital Management LLC Has $5.16 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Orion Capital Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,499 shares of the medical equipment provider’s stock after selling 170 shares during the quarter. Intuitive Surgical comprises 2.0% of Orion Capital Management LLC’s portfolio, making the stock its 10th biggest holding. Orion Capital Management LLC’s holdings in Intuitive Surgical were worth $5,162,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ISRG. Aaron Wealth Advisors LLC increased its position in Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the last quarter. Crown Wealth Group LLC grew its stake in shares of Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after buying an additional 20 shares in the last quarter. FSM Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after buying an additional 20 shares during the last quarter. CFO4Life Group LLC raised its position in shares of Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC raised its position in shares of Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Amy L. Ladd sold 335 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the transaction, the director owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company raised their price target on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Leerink Partners boosted their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $602.32.

Intuitive Surgical Stock Down 0.9%

Shares of Intuitive Surgical stock opened at $546.51 on Friday. The stock’s fifty day moving average is $458.09 and its two-hundred day moving average is $497.29. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market capitalization of $195.91 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.